Jim Gearhart, Director of Corporate Strategy and Member of Quorum Review IRB’s Board of Directors, will participate in a panel and networking discussion event focused on “The Road to eConsent.” Organized by PRC Clinical, the event will be hosted at Onyx Pharmaceuticals on Wednesday, November 18th, 2015 from 6:00pm to 8:30pm PST in Silicon Valley.
To receive the recording or attend the event in-person, please register at prcclinical.com/clinpulse. The link to view the recording will be sent to your email after the event.
The panel will be comprised of clinical trial executives, Independent Review Board (IRB) leaders, and technology vendors including:
- Mary Ann Battles, Head, Clinical Quality & Compliance, Early Development at Genentech.
- Jim Gearhart, Board of Directors at Quorum Review IRB.
- Brad Pruitt, Chief Medical Officer at Parallel 6.
- Pierre Corin, Senior Global Project Manager at Genentech will moderate the panel.
This expert panel discussion and networking event will explore the possibilities, benefits, and challenges of implementing an eConsent process for clinical studies. The eConsent or electronic informed consent (eIC) is becoming an increasingly hot topic in the clinical trial industry. Earlier this year, the FDA issued a Draft Guidance for using Informed Consent in Clinical Investigations. Shortly after that, Apple announced that its medical research app-builder, ResearchKit, has a module for building electronic consent forms.